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Introduction: Synchronous double cancers of the bile duct are exceptionally rare. We here report a case of
synchronous squamous cell carcinoma and adenocarcinoma of the extrahepatic bile duct.
Case presentation: A 67-year-old Asian man visited our clinic complaining of jaundice and dark urine.
Direct hyperbilirubinemia and an elevated cancer antigen 19–9 level were detected. Preoperative abdominal
computed tomography and positron emission tomography showed two masses at the bifurcation of the
common hepatic duct and at the distal common bile duct. After biliary drainage, we performed radical
pylorus-preserving pancreaticoduodenectomy, without resection margin involvement. Pathological findings
revealed that the proximal lesion was a squamous cell carcinoma and that the distal lesion was an adenocarcinoma.
Both cholangiocarcinomas were confined to the fibromuscular layer, and there was no communication between the
two tumors. Multiple conglomerated metastatic tumors were detected in his liver 3 months after surgery. He died 8
months after diagnosis.
Conclusions: The disease displayed very aggressive behavior and a very poor prognosis. The only chance for
long-term survival is treatment with radical resection. Preoperative positron emission tomography-computed
tomography is useful in detecting occult cancer.
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The most common malignant tumors of the bile duct
are adenocarcinomas. Squamous cell carcinomas are
very rare with an incidence of less than 1.4% according
to Funakawa et al. [1] Synchronous double primary can-
cers have occasionally been reported in the literature:
they have usually been located at the gall bladder and
the bile duct. To date, only several cases of double pri-
mary cancers of the extrahepatic bile duct have been re-
ported. All previous cases were found to be double
adenocarcinomas (Table 1). To the best of our know-
ledge, we here report the first case of synchronous pri-
mary squamous cell carcinoma and adenocarcinoma of
the extrahepatic bile duct. We also describe previous
cases and review the associated literature. In addition,* Correspondence: spmun@chosun.ac.kr
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cancers, including the efficacy of chemotherapy, radi-
ation therapy, optimal management, and prognosis.
Case presentation
A 67-year-old Asian man presented to our hospital with
yellow skin and dark urine. At first, he found his eyes
were yellow 1 month ago. Being yellow extended to his
face and trunk which was accompanied by dark urine.
He denied any fever, chills or abdominal pain. During
the past 6 months, he had lost 7kg of weight. His past
medical history was remarkable for total knee replace-
ment 5 years ago. Vital signs were within normal limits.
A physical examination revealed a chronically ill ap-
pearance and jaundice. There was no evidence of ab-
dominal distension, palpable mass, or organomegaly.
His laboratory test results were as follows: aspartate ami-
notransferase, 260U/L (normal range 5 to 40); serum
glutamic-pyruvic transaminase, 567U/L (normal range 5l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Synchronous double cancer of extrahepatic bile duct
Author Ogawa et al. [9] Bedoui et al. [10] Present study
Year 2001 2011 2013
Age (years) 69 67 67
Sex Male Female Male
Site of cancer 1 Middle CBD Distal CBD Common hepatic duct
Site of cancer 2 Distal CBD Distal CBD Distal CBD
Operation PPPD PPPD PPPD
Pathology of cancer 1 Adenocarcinoma Adenocarcinoma Squamous cell carcinoma
Pathology of cancer 2 Adenocarcinoma Adenocarcinoma Adenocarcinoma
Chemotherapy NR NR None
Prognosis NR Alive 4 months Alive 8 months
Abbreviations: CBD, common bile duct; NR, not reported; PPPD, pylorus-preserving pancreaticoduodenectomy.
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range 16 to 73); total bilirubin, 20.3mg/dL (normal range
0.2 to 1.1); direct bilirubin, 13.7mg/dL (normal range 0 to
0.6); alkaline phosphatase, 924U/L (normal range 42 to
128); and cancer antigen 19–9 (CA19-9), 125.1U/mL (nor-
mal range 0 to 33). Abdominal ultrasonography revealed a
tubular mass in the distal common bile duct (CBD), di-
lated intrahepatic bile ducts, and a distended gallbladder
(Figure 1). An abdominal computed tomography (CT)
scan showed a low-density mass at the common hepatic
duct and the distal CBD with dilatation of the intrahepatic
duct and his gall bladder (Figure 2). Positron emission
tomography (PET) revealed two tumors: one proximal
tumor with a maximum standardized uptake value (SUV)
of 8.5 and a distal tumor with a maximum SUV of 7.1
(Figure 3). We concluded that the tumors were synchron-
ous double primary cholangiocarcinomas and decided to
perform pancreaticoduodenectomy. There was no evidence
of anomalous pancreaticobiliary duct union in CT or endo-
scopic retrograde cholangiopancreatography. In the opera-
tive fields, there was no evidence of distant metastasis.
Two cholangiocarcinomas were removed with negative
surgical margin. The cut surface revealed a gray-white col-
ored, irregularly elevated, firm mass with ulceration in theFigure 1 Abdominal ultrasound. (A) A tubular mass in distal common bile
Dilated intrahepatic bile ducts.distal CBD, measuring 17×15mm. On microscopic examin-
ation we found a moderately differentiated adenocarcin-
oma which invaded the fibromuscular layer of the CBD
(stage T1b), metastasized to one regional lymph node (N1),
and showed multiple lymphovascular tumor emboli. In
addition, another mass was present just below the bifur-
cation of his hepatic duct. It was gray-white in color and
measured 15×10mm. Sections from this specimen revealed
a well-differentiated squamous cell carcinoma confined to
the fibromuscular layer (stage T1b, Figure 4). In addition
to the distinct localization of these tumors, there was no
transitional area between the two lesions and no inter-
mingled histological features favoring a diagnosis of ade-
nosquamous cell carcinoma. Taking all of these findings
into consideration, the diagnosis was synchronous double
adenocarcinoma and squamous cell carcinoma of the bile
duct. The patient displayed a good clinical course and was
discharged 23 days after surgery. However, 3 months later,
multiple liver metastases were detected. He refused treat-
ment and died 8 months after the operation.
Discussion
The annual incidence of perihilar cholangiocarcinoma
(PHC) in the USA is about 1 to 2 per 100,000. Patientsduct (arrow) and distended gallbladder and common hepatic duct. (B)
Figure 2 Abdominal computed tomography. Low density mass at common hepatic duct (black arrow head) and distal common bile duct (black
arrow) with dilatation of intrahepatic duct and gall bladder.
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aging such as CT, magnetic resonance imaging (MRI) or
PET scan is required for evaluation for distant metasta-
ses and resectability. Resectability depends on the biliary
extent of the tumor and involvement of the portal vein
and hepatic artery. Preoperative biliary drainage is rec-
ommended because of the risk of liver failure associated
with major hepatectomy in the setting of bile duct ob-
struction. Biliary drainage of the presumed remnant liver
is preferred and can be done percutaneously or endo-
scopically. A brushing biopsy is typically performed at
the time of biliary drainage, but is often indeterminate.
Pathologic confirmation of malignancy is not a require-
ment to proceed with surgical resection. Portal vein
embolization is generally recommended in patients with
a presumed remnant liver of less than 40%. At the time
of presentation, most patients with PHC have metastatic
or locally advanced disease and consequently do not
benefit from a resection. The median overall survival for
un-resected patients is about 12 months [2].
Anomalous pancreaticobiliary ductal union (APBDU)
is frequently associated with choledochal cysts and the
incidence of malignancy in choledochal cysts ranges
from 2.5 to 26%. APBDU is classified into two types: the
pancreatico-choledochal (P-C) type, in which the main
pancreatic duct enters the CBD, and the choledocho-
pancreatic (C-P) type, where the CBD enters the main
pancreatic duct. The incidence of P-C type ductal junc-
tions is higher in patients with cancer of the gallbladder,
while the incidence of C-P type junctions is higher in pa-
tients with carcinoma in congenital cystic dilatation. The
incidence of gallbladder cancer associated with APBDU
is reported to range from 16.7 to 18.3%. Neoplastic devel-
opment in the bile duct of patients with APBDU evolves
through a multistep process associated with hyperproli-
feration and genetic alterations. In one study, the K-ras
mutation was not observed at any site of cancer. However,epithelial cells in both cancerous areas showed positive
Ki-67 and it might have caused another signal regulation
apart from the K-ras gene [3]. The genetic difference be-
tween cholangiocarcinoma with APBDU and without
APBDU would give us information about the carcinogen-
esis of the two different types.
Warren and Gates defined multiple primary cancers as
follows: each tumor must present a definite picture of
malignancy, each tumor must be distinct, and the prob-
ability that one is a metastasis of the other must be ex-
cluded [4]. The case described here meets all of these
requirements. The two tumors were definitively deter-
mined to be adenocarcinoma and squamous cell carcin-
oma. There was no communication between the tumors.
In addition, there was no evidence of metastatic meta-
plasia. To the best of our knowledge, this report is the
first to describe a case of synchronous double primary
adenocarcinoma and squamous cell carcinoma of the ex-
trahepatic bile duct.
The potential origins of squamous cell carcinoma of the
biliary tree include transformation of the adenocarcinoma
to squamous cell carcinoma, derivation from the metaplas-
tic squamous epithelium of the glandular tissue, derivation
from the ectopic squamous epithelium, and derivation
from undifferentiated basal cells. In a study focusing on
adenosquamous carcinomas of the gallbladder, the growth
rate of squamous cell carcinomas exceeded that of adeno-
carcinomas, suggesting that adenocarcinomas can trans-
form into squamous cell carcinomas [5]. However, this
theory is not supported by reports of cases of pure squa-
mous cell carcinoma without adenocarcinoma compo-
nents. Thus, squamous metaplasia of the biliary mucosa
caused by inflammatory irritation or derivation from meta-
plastic squamous epithelium of glandular tissue has been
considered to be the primary mechanism. Ascariasis, clo-
norchiasis, choledochal cysts, Caroli’s disease, and primary
sclerosing cholangitis can be causative diseases. In animal
Figure 3 Positron emission tomography. Two hypermetabolic
lesions were detected. Maximum standardized uptake value of the
lesion of common hepatic duct and distal common bile duct was
8.5 and 7.1 respectively. An endoscopic nasobiliary drainage catheter
was placed preoperatively.
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junum. In some cases of cholecystitis complicated by gall-
stones, undifferentiated basal cell layers were detected in
the gall bladder. There was also a case report of an undif-
ferentiated basal cell carcinoma of the pancreas or uterus.
Based on these reports, squamous differentiation from un-
differentiated basal cells resulting in squamous cell carcin-
oma is a possibility at various sites. In the present case,however, there was no history of recurrent inflammation of
the biliary tract. Pathological findings did not reveal
squamous metaplasia or glandular components containing
squamous epithelium. Therefore, we hypothesize that the
mechanism of pathogenesis was derivation from the ectopic
squamous epithelium or from undifferentiated basal cells.
Unfortunately, there is no method to test this hypothesis.
The clinical features of squamous cell carcinoma of
the bile duct are similar to those of adenocarcinoma
with possible enhanced aggressiveness. The patient dis-
plays symptoms of biliary obstruction such as jaundice,
dark urine, itch, and weight loss. Laboratory tests reveal
direct hyperbilirubinemia and abnormal liver function.
Levels of tumor markers such CA 19–9 and carcinoem-
bryonic antigen can be elevated. The lesion is usually de-
tected preoperatively using ultrasonography, CT, MRI, or
endoscopic retrograde cholangiopancreatography. Radical
resection is the only option for long-term survival [6]. Pre-
operative detection of synchronous tumors of the bile duct
is not always possible. In addition, benign stricture, para-
sites, or gallstones can mimic cholangiocarcinoma. If the
occult cancer is present in the proximal bile duct, pan-
creaticoduodenectomy is associated with a high likelihood
of tumor cell involvement of the resection margin. In such
cases, PET-CT appears to be very useful. PET-CT provides
information not only about the malignant potential of the
lesion but also about regional and distant metastasis. In
the present case, the proximal tumor was not detected by
preoperative ultrasonography. However, both CT and
PET-CT clearly showed both tumors. A high maximum
SUV helped estimate the malignant potential of the prox-
imal lesion [7]. We were able to remove the tumor via en
bloc resection, which includes resection of the common
hepatic duct at the bifurcation.
Unlike lesions at other sites, squamous cell carcinoma
in the bile duct is resistant to radiation therapy. The
mean survival time is 3 to 8 months. One of the main
concerns is the benefit of preoperative histological diag-
nosis of squamous cell carcinoma. Gatof et al. reported
successful histological diagnosis of squamous cell carcin-
oma of the bile duct using transpapillary cholangioscopic
biopsy [8]. Currently, various thin cholangioscopes with
diameters of less than 5mm are available, which enables
us to attempt cholangioscopic biopsy of the bile duct
tumor. However, the benefit of a histological diagnosis
of squamous cell carcinoma seems to be small because it
does not affect the management plan. There is no report
regarding neoadjuvant or adjuvant combined chemoradi-
ation therapy.
Multiple carcinomas in a single organ are known to
occur in different parts of the gastrointestinal tract. Mul-
ticentric tumors were reported to occur in up to 10.7%
of colon cancer patients, 31% of pancreatic cancers pa-
tients, and 80% of esophageal cancer patients in one
Figure 4 Histopathologic findings. Adenocarcinoma of common bile duct (bottom) adjacent to reactive ductular proliferation (top) (A), which
infiltrated into fibromuscular layer with multiple tumor emboli (B). Separate lesion showing well-differentiated squamous cell carcinoma. The
tumor was observed adjacent to dilated bile ducts (C) and surface epithelium (D).
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not reported frequently and cases with double cholan-
giocarcinomas are exceptionally rare. The first case was
reported by Ogawa et al.; because the two cancers were
adenocarcinomas, they were analyzed for loss of hetero-
zygosity (LOH) to clarify whether indeed double primary
cancers were present. Both cancers showed LOH regions
at 5q, 6q, 9p, 17p, and 18q. The upper cancer showed
one additional LOH region at 8p. The presence of one
additional LOH region in the upper cancer suggests that
it was a metastasis of the lower one. Strictly speaking,
the case reported by Ogawa et al. does not meet the cri-
teria of double primary cancers [9]. Bedoui et al. re-
ported another case of double adenocarcinomas of the
CBD. The two cancers were located distal to the CBD.
Both were found to be adenocarcinoma. There was no
communication between the cancers and no periductal
lymphatic spread. The authors therefore concluded that
the adenocarcinomas were double primary cancers [10].
Double primary cancers can be defined only when the
possibility of metastasis is excluded. Although there was
no connection between the cancers, this does not
exclude the possibility of metastasis. Genetic analysis
should have been performed, as in the case reported by
Ogawa et al. In the present case, LOH analysis was not
indicated because the two cancers consisted of different
cell types: squamous cell carcinoma and adenocarcin-
oma. However, genetic analysis would provide moreinformation regarding the carcinogenesis of squamous
cell carcinoma of the bile duct.
In one study, intraductal neoplastic components showed
diffuse staining for c-Met localized in the cell membrane,
whereas 10 of the 14 cases lacked expression of c-Met in
the corresponding invasive components. In four cases,
invasive components composed of undifferentiated carcin-
oma (n=2), signet-ring cell carcinoma (n=1), and squa-
mous cell carcinoma (n=1) showed nuclear or perinuclear
staining for c-Met. Conversely, 11 of the 13 cases did not
express Ki-67 in intraductal components, whereas corre-
sponding invasive components showed diffuse nuclear
staining in all 14 cases. A comparison of the patterns of
expression between c-Met and Ki-67 at the boundary be-
tween intraductal and invasive components clearly dem-
onstrated the complementary expression of c-Met and
Ki-67. The results suggested that c-Met is involved in
early events of carcinogenesis and Ki-67 is involved in the
formation of invasive carcinoma [11].
Conclusions
To the best of our knowledge, we report the first case of
synchronous double squamous cell carcinoma and
adenocarcinoma of the extrahepatic bile duct. The dis-
ease displayed very aggressive behavior and a very poor
prognosis. The only chance for long-term survival is
treatment with radical resection. Preoperative PET-CT is
useful in detecting occult cancer.
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